Director, Chief Executive Officer · ALNYLAM PHARMACEUTICALS, INC. · Common Stock
Side
SELL
Value
$547K
Shares
1,210
Price
$452.43
Executed
Nov 12, 2025
Disclosed
Nov 14, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 12 executedNov 14, 2025 disclosed
ALNY · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Greenstreet Yvonne filed this Form 4 reporting a open-market sale of ALNY on Nov 12, 2025. It became public on Nov 14, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Greenstreet Yvonnecik:0001446125
Issuer
ALNYLAM PHARMACEUTICALS, INC.cik:0001178670
Revision history · 0
No field has changed since this record was first ingested.
